- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
B.C. Enlists 31 Producers for Adult-Use Legal Cannabis Product
The province signed memorandum of understanding deals on Wednesday (July 11) with cannabis producers and revealed the location of its first government store.
The agency tasked with overseeing the rollout of legal cannabis for adult-use in B.C. announced supply deals with 31 licensed producers (LPs), the most any province has signed for the first year of sales so far.
The Liquor Distribution Branch (LDB) for B.C. revealed on Wednesday (July 11) the initial list of licensed producers with which it had signed memorandum of understanding deals to supply legal cannabis product to the province once the recreational market opens up on October 17.
According to the LDB, the agency will continue to expand its purchasing requirements and “expects to issue a product call to invite additional licensed producers to engage as suppliers, shortly after legalization.”
The agreements were signed specifically with these producers since they “responded to the LDB’s request for information process and are able to supply a sufficient volume of non-medical cannabis upon legalization.”
Viviana Zanocco, LDB spokeswoman, told the Vancouver Sun consumers in the province are sophisticated in their use of cannabis. “Customers are used to having a lot of selection, so we wanted to make sure we have a safe, reliable supply,” she said.
In a June interview with the CBC, the Parliamentary Secretary Bill Blair said the government had been working closely with all levels of the industry and decided the delay the start of recreational sales after getting requests from the provinces.
“B.C. in particular has a lot of work to do and so we listened to the concerns that they raised,” Blair said.
Status of some producers in relation to public companies
One of the selected producers, We Grow BC, came close to being acquired by public company AREV Nutrition Sciences (CSE:AREV). On Tuesday (July 10) after its annual general meeting, AREV determined it would no longer pursue the acquisition of We Grow BC.
The company said no longer acquiring the producer benefited them with “less dilution.” The company also changed its name, pending approval from the Canadian Securities Exchange (CSE), to AREV Brands International. Stock for AREV is currently halted.
Among the several producers there exists deals with other companies holding interest or outright owning a fellow license winner producer. Aphria (TSX:APH) owns Broken Coast Cannabis while Cronos Group (TSX:CRON; NASDAQ:CRON) owns a 21.5 percent stake in Whistler Medical Marijuana.
Tilray Canada also earned a deal with the LDB through its subsidiary High Park. Tilray has announced its intentions to begin listing its class 2 common stock on the Nasdaq Global Select Market under the ticker symbol “TLRY.”
Following the announcement from LDB, confusion set in as Seven Oaks was listed as one of the producers. However Seven Oaks is not listed in the directory of LPs from Health Canada.
Deepak Anand, vice president of government relations of Cannabis Compliance voiced his concerns on his personal Twitter (NYSE:TWTR) account of the Seven Oaks deal.
Seven Oaks tweeted a mistake had been made as the producer will act as a brand for its parent company, public LP Beleave (CSE:BE).
It was signed w/ Beleave. Seven Oaks is the product brand. Not sure why we were listed as signatories.
— SevenOaks (@SevenOaksCanada) July 12, 2018
In a company statement, Seven Oaks confirmed as a brand its products will be available in B.C. through Beleave Kannabis’ deal with the province. Bealeve Kannabis obtained its initial licensing on May 2017.
“Products available in BC will include pouches of 1 [gram] and 3.5 [grams] of flower, while Seven Oaks anticipates having 1 [gram] pre-rolled joints and half-gram pre-rolled packs coming in the future,” the company stated.
Despite a lack of details from a variety of the producers on the amount of product each one will be supplying to the province, Maricann (CSE:MARI) disclosed it will “allocate a minimum of 3,621,900 grams per year to the BCLDB.”
Aphria and Canopy Growth (TSX:WEED; NYSE:CGC) both revealed on Thursday (July 12) how much product they would send to B.C. during the first year of legal sales. Canopy will offer 5,719 kilograms while Aphria will provide 5,000 kilograms.
First retail stores in the province
The LDB also revealed its first retail cannabis store will be located in Kamloops within the Kamloops’ Columbia Place Shopping Centre. In B.C. the plan is to allow private retail shops to co-exist with the government owned and operated cannabis shops.
For its online component the LDB announced in June it had selected Shopify (TSX:SHOP) as its platform for online sales of recreational cannabis products. The online platform is set to create two new websites selling cannabis, one for consumers and the second for private retail shops.
Here’s the complete list of cannabis producers tapped by the province’s liquor board to supply the government run retail stores and the respective public company associated with some producers:
- Acreage Pharms – Invictus MD (TSXV:GENE)
- Agrima Botanicals (private)
- Aphria
- Aurora Cannabis (TSX:ACB)
- Bloomera – Ravenquest BioMed (CSE:RQB)
- Broken Coast Cannabis – Aphria
- Canna Farms – ABcann Global (TSXV:ABCN)
- CannTrust (TSX:TRST)
- Canopy Growth
- Cronos Group
- DOJA Cannabis – Hiku Brands (CSE:HIKU)
- Evergreen Medicinal Supply (private)
- Experion Biotechnologies – Viridium Pacific Group (TSXV:VIR)
- Hydropothecary (TSXV:HEXO)
- Maricann
- MedReleaf (TSX:LEAF)
- Natural Med Company – Eve & Co Incorporated (TSXV:EVE)
- Redecan Pharm (private)
- Seven Oaks – Beleave
- Solace Health (TerrAscend Corp. CSE:TER)
- Starseed Medicinal (private)
- THC BioMed (CSE:THC)
- The Flowr Corporation (private)
- 7ACRES – The Supreme Cannabis Company (TSXV:FIRE)
- Tilray Canada (NASDAQ:TLRY)
- United Greeneries – Harvest One (TSXV:HVT)
- Up Cannabis – Newstrike Cannabis (TSXV:HIP)
- We Grow BC
- WeedMD (TSXV:WMD)
- Whistler Medical Marijuana – Active stake owned by Cronos Group
- Zenabis (private)
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.
Editorial Disclosure: Beleave, Maricann, Hiku Brands, The Supreme Cannabis Company and Harvest One are clients of the Investing News Network. This article is not paid-for content.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.